|
1
|
Weaver BA: How Taxol/paclitaxel kills
cancer cells. Mol Biol Cell. 25:2677–2681. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rowinsky EK, Cazenave LA and Donehower RC:
Taxol: A novel investigational antimicrotubule agent. J Natl Cancer
Inst. 82:1247–1259. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Danesi R, Figg WD, Reed E and Myers CE:
Paclitaxel (taxol) inhibits protein isoprenylation and induces
apoptosis in PC-3 human prostate cancer cells. Mol Pharmacol.
47:1106–1111. 1995.PubMed/NCBI
|
|
4
|
Obasaju C and Hudes GR: Paclitaxel and
docetaxel in prostate cancer. Hematol Oncol Clin North Am.
15:525–545. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kopczyńska E: Role of microRNAs in the
resistance of prostate cancer to docetaxel and paclitaxel. Contemp
Oncol (Pozn). 19:423–427. 2015.PubMed/NCBI
|
|
6
|
Sobue S, Mizutani N, Aoyama Y, Kawamoto Y,
Suzuki M, Nozawa Y, Ichihara M and Murate T: Mechanism of
paclitaxel resistance in a human prostate cancer cell line, PC3-PR,
and its sensitization by cabazitaxel. Biochem Biophys Res Commun.
479:808–813. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Grimm EA, Sikora AG and Ekmekcioglu S:
Molecular pathways: Inflammation-associated nitric-oxide production
as a cancer-supporting redox mechanism and a potential therapeutic
target. Clin Cancer Res. 19:5557–5563. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Laschak M, Spindler KD, Schrader AJ,
Hessenauer A, Streicher W, Schrader M and Cronauer MV: JS-K, a
glutathione/glutathione S-transferase-activated nitric oxide
releasing prodrug inhibits androgen receptor and WNT-signaling in
prostate cancer cells. BMC Cancer. 12:1302012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tan G, Qiu M, Chen L, Zhang S, Ke L and
Liu J: JS-K, a nitric oxide pro-drug, regulates growth and
apoptosis through the ubiquitin-proteasome pathway in prostate
cancer cells. BMC Cancer. 17:3762017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Qiu M, Chen L, Tan G, Ke L, Zhang S, Chen
H and Liu J: JS-K promotes apoptosis by inducing ROS production in
human prostate cancer cells. Oncol Lett. 13:1137–1142. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Qiu M, Ke L, Zhang S, Zeng X, Fang Z and
Liu J: JS-K, a GST-activated nitric oxide donor prodrug, enhances
chemo-sensitivity in renal carcinoma cells and prevents cardiac
myocytes toxicity induced by Doxorubicin. Cancer Chemother
Pharmacol. 80:275–286. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang SQ, Wang C, Chang LM, Zhou KR, Wang
JW, Ke Y, Yang DX, Shi HG, Wang R, Shi XL, et al: Geridonin and
paclitaxel act synergistically to inhibit the proliferation of
gastric cancer cells through ROS-mediated regulation of the
PTEN/PI3K/Akt pathway. Oncotarget. 7:72990–73002. 2016.PubMed/NCBI
|
|
14
|
Ouyang L, Shi Z, Zhao S, Wang FT, Zhou TT,
Liu B and Bao JK: Programmed cell death pathways in cancer: A
review of apoptosis, autophagy and programmed necrosis. Cell
Prolif. 45:487–498. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Elmore S: Apoptosis: A review of
programmed cell death. Toxicol Pathol. 35:495–516. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu WS: The signaling mechanism of ROS in
tumor progression. Cancer Metastasis Rev. 25:695–705. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ray PD, Huang BW and Tsuji Y: Reactive
oxygen species (ROS) homeostasis and redox regulation in cellular
signaling. Cell Signal. 24:981–990. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Qiu M, Chen L, Tan G, Ke L, Zhang S, Chen
H and Liu J: A reactive oxygen species activation mechanism
contributes to JS-K-induced apoptosis in human bladder cancer
cells. Sci Rep. 5:151042015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nie F, Zhang X, Qi Q, Yang L, Yang Y, Liu
W, Lu N, Wu Z, You Q and Guo Q: Reactive oxygen species
accumulation contributes to gambogic acid-induced apoptosis in
human hepatoma SMMC-7721 cells. Toxicology. 260:60–67. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Song X, Xie L, Wang X, Zeng Q, Chen TC,
Wang W and Song X: Temozolomide-perillyl alcohol conjugate induced
reactive oxygen species accumulation contributes to its
cytotoxicity against non-small cell lung cancer. Sci Rep.
6:227622016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Brigelius-Flohé R and Maiorino M:
Glutathione peroxidases. Biochim Biophys Acta. 1830:3289–3303.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Giampazolias E and Tait SW: Mitochondria
and the hallmarks of cancer. FEBS J. 283:803–814. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Allan LA and Clarke PR: Apoptosis and
autophagy: Regulation of caspase-9 by phosphorylation. FEBS J.
276:6063–6073. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cosentino K and García-Sáez AJ:
Mitochondrial alterations in apoptosis. Chem Phys Lipids.
181:62–75. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kvansakul M and Hinds MG: The Bcl-2
family: Structures, interactions and targets for drug discovery.
Apoptosis. 20:136–150. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Siddiqui WA, Ahad A and Ahsan H: The
mystery of BCL2 family: Bcl-2 proteins and apoptosis: An update.
Arch Toxicol. 89:289–317. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tasyriq M, Najmuldeen IA, In LL, Mohamad
K, Awang K and Hasima N: 7α-hydroxy-β-sitosterol from chisocheton
tomentosus induces apoptosis via dysregulation of cellular
Bax/Bcl-2 ratio and cell cycle arrest by downregulating ERK1/2
activation. Evid Based Complement Alternat Med. 2012:7653162012.
View Article : Google Scholar : PubMed/NCBI
|
